In this case, according to our results, for K-RasG13D mutant colon cancer, PI3K/Akt/mTOR or RAS/ERK pathway inhibitor (BEZ235 or SCH772984) alone would be a better treatment option than S7333 alone. Here, MAPK1 is linked to malignant colon neoplasm.